Deliver Your News to the World

Sight Diagnostics Named To Fast Company’s Annual List Of The World’s Most Innovative Companies for 2019

The company lands the number one spot in the Middle East category as it brings patients access to accurate, convenient and pain-free diagnostic testing that delivers results in minutes instead of days

Tel Aviv, Israel – WEBWIRE

On February 20, 2019, Fast Company announced the winners of its prestigious annual list, the World’s Most Innovative Companies for 2019, which honors the businesses making the most profound impact on both industry and culture, showcasing a variety of ways to thrive in today’s volatile world. Among those honored is Sight Diagnostics, the company working to provide patients with lab-grade blood testing results in minutes rather than days by combining AI with a revolutionary method to ’digitize’ blood. 

“In the past few years, Israel has risen to prominence as one of the world’s great innovation hubs,” said Yossi Pollak, co-founder and CEO of Sight Diagnostics. “There are hundreds of companies based here that are working tirelessly to make the world a better place. We are incredibly proud to be recognized as the most innovative company in the Middle East, but are also grateful for the extraordinary startup culture in Israel that made it possible.” 

In July 2018, Sight Diagnostics launched OLO, an AI-based blood diagnostics platform, which offers lab-quality Complete Blood Count (CBC) tests – the world’s most common blood test. OLO allows patients to receive their blood test results within minutes at the point-of-care, rather than making them wait days to receive results, so that accurate treatment can be delivered faster. Sight’s patented method of “digitizing” blood – which takes extremely detailed images of blood and then analyzes them with AI-based computer vision algorithms – was first deployed in African countries and India in 2014, where it was used to detect malaria with exceptional accuracy and at low cost. In addition to traditional venous blood draws, OLO is able to test fingerprick blood samples, requiring only a couple of drops of blood.

Additionally, Sight recently announced a $27.8 million Series C funding led by Longliv Ventures, a member of the CK Hutchison Group –  a multinational conglomerate whose portfolio includes more than 14,900 health and beauty stores across Europe and Asia. Keeping with a focus on strategic investment, other investors that joined the round also contribute to Sight’s technological and commercial expansion. The company is using the funding to continue the global commercialization of OLO, support Sight’s regulatory efforts in the US, and expand OLO’s menu of diagnostic tests.

This year, Fast Company’s editors and writers sought out groundbreaking businesses across 35 industries and every region. They also judged nominations received through their application process.

The World’s Most Innovative Companies is Fast Company’s signature franchise and one of its most highly anticipated editorial efforts of the year. It provides both a snapshot and a road map for the future of innovation across the most dynamic sectors of the economy. 

“Established players are showing the same kind of nimbleness that we’ve generally associated with startups,” said Fast Company deputy editor David Lidsky, who oversaw the issue with senior editor Amy Farley.

Fast Company’s Most Innovative Companies issue (March-April 2019) is now available online at, as well as in app form via iTunes and on newsstands beginning February 27th. The hashtag is #fcmostinnovative. 

Sight was created to provide patients with access to accurate, convenient and pain-free diagnostic testing that delivers results in minutes instead of days, in order to transform healthcare. To do so, Sight has developed an artificial intelligence-driven platform for blood analysis and infectious disease diagnostics based on its revolutionary methods for ‘digitizing’ blood. The company’s platform was first deployed in 2014 to detect malaria, for which over 600,000 tests have been sold across 25 countries. The company’s newest offering, OLO, brings lab-grade Complete Blood Counts (CBCs) to the point-of-care and is now available for purchase in the EU. Sight was founded by a team that includes Harvard-trained biotechnologists, experts in AI, and instrumentation engineers, many of whom hail from the world-renowned IDF technology units.
In the United States, OLO is an investigational system and is not yet available for sale. 
For more information on OLO, please visit

Fast Company is the only media brand fully dedicated to the vital intersection of business, innovation, and design, engaging the most influential leaders, companies and thinkers on the future of business. Since 2011, Fast Company has received some of the most prestigious editorial and design accolades, including the American Society of Magazine Editors (ASME) National Magazine Award for “Magazine Of The Year,” Adweek’s Hot List for “Hottest Business Publication,” and six gold medals and 10 silver medals from the Society of Publication Designers. The editor-in-chief is Stephanie Mehta and the publisher is Amanda Smith. Headquartered in New York City, Fast Company is published by Mansueto Ventures LLC, along with our sister publication Inc., and can be found online at

Media Contact
Emma Baron
Senior Account Executive
VSC for Sight Diagnostics



 Sight Diagnostics
 CK Hutchison
 Longliv Ventures
 Most Innovative Companies
 Fast Company

This news content may be integrated into any legitimate news gathering and publishing effort. Linking is permitted.

News Release Distribution and Press Release Distribution Services Provided by WebWire.